Skip to main content

Continuous Positive Airway Pressure

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pulmodyne
PulmodyneIN - Indianapolis
1 program
CPAP mask systemN/A1 trial
Active Trials
NCT04186598Completed64Est. Sep 2023
Eppendorf
EppendorfGermany - Hamburg
1 program
SuperNO2VA™ Et by Vyaire Medical, Inc.N/A1 trial
Active Trials
NCT06168682Completed158Est. Jun 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
EppendorfSuperNO2VA™ Et by Vyaire Medical, Inc.
PulmodyneCPAP mask system

Clinical Trials (2)

Total enrollment: 222 patients across 2 trials

NCT06168682EppendorfSuperNO2VA™ Et by Vyaire Medical, Inc.

Nasal CPAP - The Treatment IMpact on Oxygenation in High-risk Patients During Deep Sedation for Endoscopy

Start: Nov 2023Est. completion: Jun 2024158 patients
N/ACompleted
NCT04186598PulmodyneCPAP mask system

Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema

Start: Jan 2020Est. completion: Sep 202364 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.